Axonics, Inc. (NASDAQ:AXNX) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Axonics' Fourth Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.
Axonics Inc. (AXNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polar Capital Brian Ashford-Russell And Tim Woolley | 710,336 | $44,417,310 | 0.35% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 626,135 | $39,152,223 | -25% | 0.08% |
| 3. | Citadel Investment Group Ken Griffin | 525,352 | $32,850,261 | +56% | 0% |
| 4. | Driehaus Capital Richard Driehaus | 287,238 | $17,960,992 | -56% | 0.26% |
| 5. | GLG Partners Noam Gottesman | 263,478 | $16,475,280 | +26% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.41 | 3,500 | 683,391 | 2019-08-06 | Filing | ||
| $37.12 | 2,000 | 7,000 | 2019-06-27 | Filing | ||
| $15.00 | 866,666 | Large Shareholder, Director | 3,133,332 | 2018-11-02 | Filing | |
| $15.00 | 866,666 | Large Shareholder | 3,557,461 | 2018-11-02 | Filing | |
| $15.00 | 866,666 | Large Shareholder, Director | 3,557,461 | 2018-11-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.53 | 3,392 | 608 | 2023-02-21 | Filing | ||
| $56.69 | 3,700 | 55,854 | 2023-02-21 | Filing | ||
| $56.18 | 16,229 | 59,554 | 2023-02-21 | Filing | ||
| $61.02 | 4,334 | 75,783 | 2023-02-01 | Filing | ||
| $60.43 | 741 | 80,117 | 2023-02-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,863,283 | $304,101,087 | 0% | |
| 2. | 3,630,843 | $227,036,612 | 0% | |
| 3. | 2,718,793 | $170,006,113 | 0.01% | |
| 4. | 1,929,567 | $120,655,824 | 0.03% | |
| 5. | 1,906,461 | $119,211,006 | 1.58% |
News See All
12 Most Promising Medical Stocks According to Analysts
Regardless of the short-term market situation, the healthcare industry has a huge growth potential.
Should You Invest in Axonics (AXNX)?
Chartwell Investment Partners, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Small Cap Growth Fund” third quarter 2022 investor letter...
Why Axonics (AXNX) Surged in the Third Quarter?
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Baron Funds: "We are Excited About Axonics (AXNX)’s Future Growth Prospects"
Baron Funds, an asset management firm, published its “Baron Discovery Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
14 Stocks to Buy According to Daniel Kim's Blackcrane Capital
In this article, we take a look at 14 stocks to buy according to Daniel Kim's Blackcrane Capital.
Is Axonics Inc. (AXNX) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Dumping Axonics, Inc. (AXNX)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is AXNX Stock A Buy or Sell?
With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first ...
Hedge Funds Are Crazy About Axonics Modulation Technologies, Inc. (AXNX)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Billionaire Hedge Funds
